BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Gorelik E, Masarwa R, Perlman A, Rotshild V, Abbasi M, Muszkat M, Matok I. Fluoroquinolones and Cardiovascular Risk: A Systematic Review, Meta-analysis and Network Meta-analysis. Drug Saf 2019;42:529-38. [PMID: 30368737 DOI: 10.1007/s40264-018-0751-2] [Cited by in Crossref: 29] [Cited by in F6Publishing: 21] [Article Influence: 14.5] [Reference Citation Analysis]
Number Citing Articles
1 Shah SC, Shah S, Halvorson AE, Hung A, Greevy RA Jr, Roumie CL. Helicobacter pylori eradication therapy is not associated with increased risk of cardiovascular mortality, based on a national cohort study. Gastro Hep Adv 2022;1:25-8. [PMID: 35253008 DOI: 10.1016/j.gastha.2021.10.003] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Bastida C, Soy D, Torres A. The safety of antimicrobials for the treatment of community-acquired pneumonia. Expert Opin Drug Saf 2020;19:577-87. [PMID: 32239981 DOI: 10.1080/14740338.2020.1750594] [Reference Citation Analysis]
3 Althaqafi A, Ali M, Alzahrani Y, Ming LC, Hussain Z. How Safe are Fluoroquinolones for Diabetic Patients? A Systematic Review of Dysglycemic and Neuropathic Effects of Fluoroquinolones. Ther Clin Risk Manag 2021;17:1083-90. [PMID: 34675522 DOI: 10.2147/TCRM.S284171] [Reference Citation Analysis]
4 Baggio D, Ananda-Rajah MR. Fluoroquinolone antibiotics and adverse events. Aust Prescr 2021;44:161-4. [PMID: 34728881 DOI: 10.18773/austprescr.2021.035] [Reference Citation Analysis]
5 Majalekar PP, Shirote PJ. Fluoroquinolones: Blessings Or Curses. Curr Drug Targets 2020;21:1354-70. [PMID: 32564750 DOI: 10.2174/1389450121666200621193355] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
6 Li S, Chen Z, Huang L, Liu Z, Shi Y, Zhang M, Li H, Zeng L, Ni J, Zhu Y, Jia ZJ, Cheng G, Zhang L. Safety of Quinolones in Children: A Systematic Review and Meta-Analysis. Paediatr Drugs 2022. [PMID: 35771411 DOI: 10.1007/s40272-022-00513-2] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Cordova Sanchez A, Chohan M, Olatunde O, White C. A Rare Case of Ciprofloxacin-Induced Bradycardia Recognized by a Smartwatch. J Investig Med High Impact Case Rep 2022;10:23247096211069761. [PMID: 35073779 DOI: 10.1177/23247096211069761] [Reference Citation Analysis]
8 Magri V, Stamatiou K, Trinchieri A, Perletti G. Commentary: Pharmacological Interventions for Bacterial Prostatitis. Front Pharmacol 2020;11:573903. [PMID: 33123012 DOI: 10.3389/fphar.2020.573903] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
9 Klotzbaugh RJ, Martin A, Turner JR. Drug-induced proarrhythmia: Discussion and considerations for clinical practice. JAAPA 2020;33:1-7. [PMID: 31990841 DOI: 10.1097/01.JAA.0000651776.53223.e7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Rusu A, Lungu IA, Moldovan OL, Tanase C, Hancu G. Structural Characterization of the Millennial Antibacterial (Fluoro)Quinolones-Shaping the Fifth Generation. Pharmaceutics 2021;13:1289. [PMID: 34452252 DOI: 10.3390/pharmaceutics13081289] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 9.0] [Reference Citation Analysis]
11 Chen YY, Yang SF, Yeh HW, Yeh YT, Huang JY, Tsao SL, Yeh CB. Association Between Aortic Aneurysm and Aortic Dissection With Fluoroquinolones Use in Patients With Urinary Tract Infections: A Population-Based Cohort Study. J Am Heart Assoc 2022;11:e023267. [PMID: 35229623 DOI: 10.1161/JAHA.121.023267] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Knoll KE, Lindeque Z, Adeniji AA, Oosthuizen CB, Lall N, Loots DT. Elucidating the Antimycobacterial Mechanism of Action of Ciprofloxacin Using Metabolomics. Microorganisms 2021;9:1158. [PMID: 34071153 DOI: 10.3390/microorganisms9061158] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
13 Jun C, Fang B. Current progress of fluoroquinolones-increased risk of aortic aneurysm and dissection. BMC Cardiovasc Disord 2021;21:470. [PMID: 34583637 DOI: 10.1186/s12872-021-02258-1] [Reference Citation Analysis]
14 Suzuki H, Perencevich EN, Alexander B, Beck BF, Goto M, Lund BC, Nair R, Livorsi DJ. Inpatient Fluoroquinolone Stewardship Improves the Quantity and Quality of Fluoroquinolone Prescribing at Hospital Discharge: A Retrospective Analysis Among 122 Veterans Health Administration Hospitals. Clin Infect Dis 2020;71:1232-9. [PMID: 31562815 DOI: 10.1093/cid/ciz967] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
15 Shen R, Yu Y, Lan R, Yu R, Yuan Z, Xia Z. The cardiovascular toxicity induced by high doses of gatifloxacin and ciprofloxacin in zebrafish. Environmental Pollution 2019;254:112861. [DOI: 10.1016/j.envpol.2019.07.029] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 6.0] [Reference Citation Analysis]
16 Klotzbaugh RJ, Martin A, Turner JR. Drug-induced proarrhythmia: Discussion and considerations for clinical practice. J Am Assoc Nurse Pract 2020;32:128-35. [PMID: 32015278 DOI: 10.1097/JXX.0000000000000348] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
17 Rotshild V, Hirsh-Raccah B, Miskin I, Muszkat M, Matok I. Comparing the clinical efficacy of COVID-19 vaccines: a systematic review and network meta-analysis. Sci Rep 2021;11:22777. [PMID: 34815503 DOI: 10.1038/s41598-021-02321-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
18 Perletti G, Trinchieri A, Stamatiou K, Magri V. Safety considerations with new antibacterial approaches for chronic bacterial prostatitis. Expert Opin Drug Saf 2021;:1-12. [PMID: 34260337 DOI: 10.1080/14740338.2021.1956459] [Reference Citation Analysis]
19 Li Z, Liu K, Zhao J, Yang L, Chen G, Liu A, Wang Q, Wang S, Li X, Cao H, Tao F, Zhang D. Antibiotics in elderly Chinese population and their relations with hypertension and pulse pressure. Environ Sci Pollut Res Int 2022. [PMID: 35513617 DOI: 10.1007/s11356-022-20613-3] [Reference Citation Analysis]
20 Franchi C, Mandelli S, Fortino I, Nobili A. Antibiotic use and associated factors in adult outpatients from 2000 to 2019. Pharmacol Res Perspect 2021;9:e00878. [PMID: 34664793 DOI: 10.1002/prp2.878] [Reference Citation Analysis]
21 Nibell O, Svanström H, Inghammar M. Oral fluoroquinolone use and the risk of acute liver injury: a nationwide cohort study. Clin Infect Dis 2021:ciab825. [PMID: 34537834 DOI: 10.1093/cid/ciab825] [Reference Citation Analysis]
22 Borshchev YY, Minasian SM, Burovenko IY, Borshchev VY, Protsak ES, Semenova NY, Borshcheva OV, Galagudza MM. Effects of tetracycline on myocardial infarct size in obese rats with chemically-induced colitis. PLoS One 2019;14:e0225185. [PMID: 31714931 DOI: 10.1371/journal.pone.0225185] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
23 Serota DP, Chueng TA, Schechter MC. Applying the Infectious Diseases Literature to People who Inject Drugs. Infect Dis Clin North Am 2020;34:539-58. [PMID: 32782101 DOI: 10.1016/j.idc.2020.06.010] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
24 Manfredi C, Calace FP, Fusco F, Quattrone C, Giordano D, Crocetto F, Creta M, De Sio M, Arcaniolo D. Escherichia coli Nissle 1917 as adjuvant therapy in patients with chronic bacterial prostatitis: a non-blinded, randomized, controlled trial. World J Urol 2021. [PMID: 34213584 DOI: 10.1007/s00345-021-03773-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
25 Georgi U, Tesch F, Schmitt J, de With K. Impact of safety warnings for fluoroquinolones on prescribing behaviour. Results of a cohort study with outpatient routine data. Infection 2021;49:447-55. [PMID: 33258075 DOI: 10.1007/s15010-020-01549-7] [Reference Citation Analysis]
26 Kuula LSM, Backman JT, Blom ML. Health service use and costs associated with fluoroquinolone-related tendon injuries. Pharmacol Res Perspect 2021;9:e00796. [PMID: 34086409 DOI: 10.1002/prp2.796] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
27 Saad NA, Elberry AA, Samy Matar H, Hussein RRS. Effect of ciprofloxacin vs levofloxacin on QTc-interval and dysglycemia in diabetic and non-diabetic patients. Int J Clin Pract 2021;75:e14072. [PMID: 33559294 DOI: 10.1111/ijcp.14072] [Reference Citation Analysis]
28 Hu WP, Lhamo T, Zhang FY, Hang JQ, Zuo YH, Hua JL, Li SQ, Zhang J. Predictors of acute cardiovascular events following acute exacerbation period for patients with COPD: a nested case-control study. BMC Cardiovasc Disord 2020;20:518. [PMID: 33302869 DOI: 10.1186/s12872-020-01803-8] [Reference Citation Analysis]
29 Simonsen JR, Järvinen A, Harjutsalo V, Forsblom C, Groop PH, Lehto M. The association between bacterial infections and the risk of coronary heart disease in type 1 diabetes. J Intern Med 2020;288:711-24. [PMID: 32754939 DOI: 10.1111/joim.13138] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
30 Heianza Y, Ma W, Li X, Cao Y, Chan AT, Rimm EB, Hu FB, Rexrode KM, Manson JE, Qi L. Duration and Life-Stage of Antibiotic Use and Risks of All-Cause and Cause-Specific Mortality: Prospective Cohort Study. Circ Res 2020;126:364-73. [PMID: 31842690 DOI: 10.1161/CIRCRESAHA.119.315279] [Cited by in Crossref: 7] [Cited by in F6Publishing: 1] [Article Influence: 2.3] [Reference Citation Analysis]
31 Assimon MM, Pun PH, Wang LC, Al-Khatib SM, Brookhart MA, Weber DJ, Winkelmayer WC, Flythe JE. Analysis of Respiratory Fluoroquinolones and the Risk of Sudden Cardiac Death Among Patients Receiving Hemodialysis. JAMA Cardiol 2021. [PMID: 34668928 DOI: 10.1001/jamacardio.2021.4234] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
32 Aspinall SL, Sylvain NP, Zhao X, Zhang R, Dong D, Echevarria K, Glassman PA, Goetz MB, Miller DR, Cunningham FE. Serious cardiovascular adverse events with fluoroquinolones versus other antibiotics: A self-controlled case series analysis. Pharmacol Res Perspect 2020;8:e00664. [PMID: 33047487 DOI: 10.1002/prp2.664] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
33 Agnoletti D, Piani F, Cicero AFG, Borghi C. The Gut Microbiota and Vascular Aging: A State-of-the-Art and Systematic Review of the Literature. J Clin Med 2022;11:3557. [PMID: 35743626 DOI: 10.3390/jcm11123557] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
34 Muanda FT, Sood MM, Weir MA, Sontrop JM, Ahmadi F, Yoo E, Kim RB, Silverman MS, Knoll GA, Garg AX. Association of Higher-Dose Fluoroquinolone Therapy With Serious Adverse Events in Older Adults With Advanced Chronic Kidney Disease. JAMA Netw Open 2022;5:e2224892. [PMID: 35917124 DOI: 10.1001/jamanetworkopen.2022.24892] [Reference Citation Analysis]
35 Newman LM, Kankam M, Nakamura A, Conrad T, Mueller J, O'Donnell J, Osborn BL, Gu K, Saviolakis GA. Thorough QT Study To Evaluate the Effect of Zoliflodacin, a Novel Therapeutic for Gonorrhea, on Cardiac Repolarization in Healthy Adults. Antimicrob Agents Chemother 2021;65:e0129221. [PMID: 34606332 DOI: 10.1128/AAC.01292-21] [Reference Citation Analysis]